Simian Immunodeficiency Virus SIVgsn-99CM71 Vpu Employs Different Amino Acids To Antagonize Human and Greater Spot-Nosed Monkey BST-2

Abstract

Viral protein U (Vpu) is an accessory protein encoded by human immunodeficiency virus type 1 (HIV-1) and certain simian immunodeficiency virus (SIV) strains. Some of these viruses were reported to use Vpu to overcome restriction by BST-2 of their natural hosts. Our own recent report revealed that Vpu of SIVgsn-99CM71 (SIVgsn71) antagonizes human BST-2 through two AxxxxxxxW motifs (A 22 W 30 and A 25 W 33 ) whereas antagonizing BST-2 of its natural host, greater spot-nosed monkey (GSN), involved only A 22 W 30 motif. Here we show that residues A 22 , A 25 , W 30 , and W 33 of SIVgsn71 Vpu are all essential to antagonize human BST-2, while, neither single mutation of A 22 nor W 30 affected the ability to antagonize GSN BST-2. Similar to A 18 , which is located in the middle of the A 14 xxxxxxxW 22 motif in HIV-1 NL4-3 Vpu and is essential to antagonize human BST-2, A 29 , located in the middle of the A 25 W 33 motif of SIVgsn71 Vpu was found to be necessary for antagonizing human but not GSN BST-2. Further mutational analyses revealed that residues L 21 and K 32 of SIVgsn71 Vpu were also essential for antagonizing human BST-2. On the other hand, the ability of SIVgsn71 Vpu to target GSN BST-2 was unaffected by single amino acid substitutions but required multiple mutations to render SIVgsn71 Vpu inactive against GSN BST-2. These results suggest additional requirements for SIVgsn71 Vpu antagonizing human BST-2, implying evolution of the bst-2 gene under strong selective pressure. Importance Genes related to survival against life-threating pathogens are important determinants of natural selection in animal evolution. For instance, BST-2, a protein showing broad-spectrum antiviral activity, shows polymorphisms entailing different phenotypes even among primate species, suggesting that the bst-2 gene of primates has been subject to strong selective pressure during evolution. At the same time, viruses readily adapt to these evolutionary changes. Thus, we found that Vpu of an SIVgsn isolate (SIVgsn-99CM71) can target BST-2 from humans as well as from its natural host thus potentially facilitating zoonosis. Here we mapped residues in SIVgsn71 Vpu potentially contributing to cross-species transmission. We found that the requirements for targeting human BST-2 are distinct from and more complex than those for targeting GSN BST-2. Our results suggest that the human bst-2 gene might have evolved to acquire more restrictive phenotype than GSN bst-2 against viral proteins after being derived from their common ancestor.

Possible acquisition and molecular evolution ofvpugenes inferred from comprehensive sequence analysis of human and simian immunodeficiency viruses

“…The transmembrane domain contains motifs involved in tetherin antagonism, whereas the cytoplasmic domain contains motifs related to the downregulation of CD4 + T cells. It has been established that the AxxxAxxxAxxxW, AxxxAxxxAxLL, and AxxxxxxxW residues in the transmembrane domain play a crucial role in the anti-tetherin activity of HIV-1 groups M (Vpu-type 4a) and N (Vpu-type 4b) and SIVgsn (Vpu-type 1), respectively (Douglas et al, 2013; Sauter et al, 2012; Yao et al, 2022). Interestingly, the DSGxxS motif, which is crucial for the proteasomal degradation of CD4 + T cells, is partly conserved in Vpu-type 1 because it contains only one of the double serine residues required for this function.…”